Computed tomography predictors of hepatocellular carcinoma tumour necrosis after chemoembolization. Issue 4 (26th August 2013)
- Record Type:
- Journal Article
- Title:
- Computed tomography predictors of hepatocellular carcinoma tumour necrosis after chemoembolization. Issue 4 (26th August 2013)
- Main Title:
- Computed tomography predictors of hepatocellular carcinoma tumour necrosis after chemoembolization
- Authors:
- Bryant, Mary K.
Dorn, David P.
Zarzour, Jessica
Smith, J. Kevin
Redden, David T.
Saddekni, Souheil
Aal, Ahmed Kamel Abdel
Gray, Stephen H.
Eckhoff, Devin E.
DuBay, Derek A. - Abstract:
- <abstract abstract-type="main"> <title>Abstract</title> <sec id="hpb12149-sec-0001" sec-type="section"> <title>Background</title> <p>Radiographical features associated with a favourable response to trans‐arterial chemoembolization (TACE) are poorly defined for patients with hepatocellular carcinoma (HCC).</p> </sec> <sec id="hpb12149-sec-0002" sec-type="section"> <title>Methods</title> <p>From 2008 to 2012, all first TACE interventions for HCC performed at the University of Alabama at Birmingham (UAB) were retrospectively reviewed. Only patients with a pre‐TACE and a post‐TACE computed tomography (CT) scan were included in the analyses (<italic>n</italic> = 115). HCC tumour response to TACE was quantified via the the modified Response Evaluation Criteria in Solid Tumors (mRECIST) criteria. Univariate and multivariable analyses were constructed.</p> </sec> <sec id="hpb12149-sec-0003" sec-type="section"> <title>Results</title> <p>The index HCC tumours experienced a &gt; 90% or complete tumour necrosis in 59/115 (51%) of patients after the first TACE intervention. On univariate analysis, smaller tumour size, peripheral tumour location and arterial enhancement were associated with a &gt; 90% or complete tumour necrosis, whereas, only smaller tumour size [odds ratio (OR) 0.62; 95% confidence interval (CI) 0.48, 0.81] and peripheral location (OR 6.91; 95% CI 1.75, 27.29) were significant on multivariable analysis. There was a trend towards improved survival in the patients that<abstract abstract-type="main"> <title>Abstract</title> <sec id="hpb12149-sec-0001" sec-type="section"> <title>Background</title> <p>Radiographical features associated with a favourable response to trans‐arterial chemoembolization (TACE) are poorly defined for patients with hepatocellular carcinoma (HCC).</p> </sec> <sec id="hpb12149-sec-0002" sec-type="section"> <title>Methods</title> <p>From 2008 to 2012, all first TACE interventions for HCC performed at the University of Alabama at Birmingham (UAB) were retrospectively reviewed. Only patients with a pre‐TACE and a post‐TACE computed tomography (CT) scan were included in the analyses (<italic>n</italic> = 115). HCC tumour response to TACE was quantified via the the modified Response Evaluation Criteria in Solid Tumors (mRECIST) criteria. Univariate and multivariable analyses were constructed.</p> </sec> <sec id="hpb12149-sec-0003" sec-type="section"> <title>Results</title> <p>The index HCC tumours experienced a &gt; 90% or complete tumour necrosis in 59/115 (51%) of patients after the first TACE intervention. On univariate analysis, smaller tumour size, peripheral tumour location and arterial enhancement were associated with a &gt; 90% or complete tumour necrosis, whereas, only smaller tumour size [odds ratio (OR) 0.62; 95% confidence interval (CI) 0.48, 0.81] and peripheral location (OR 6.91; 95% CI 1.75, 27.29) were significant on multivariable analysis. There was a trend towards improved survival in the patients that experienced a &gt; 90% or complete tumour necrosis (<italic>P</italic> = 0.08).</p> </sec> <sec id="hpb12149-sec-0004" sec-type="section"> <title>Conclusions</title> <p>Peripherally located smaller HCC tumours are most likely to experience a &gt; 90% or complete tumour necrosis after TACE. Surprisingly, arterial‐phase enhancement and portal venous‐phase washout were not significantly predictive of TACE‐induced tumour necrosis. The TACE response was not statistically associated with improved survival.</p> </sec> </abstract> … (more)
- Is Part Of:
- HPB. Volume 16:Issue 4(2014:Apr.)
- Journal:
- HPB
- Issue:
- Volume 16:Issue 4(2014:Apr.)
- Issue Display:
- Volume 16, Issue 4 (2014)
- Year:
- 2014
- Volume:
- 16
- Issue:
- 4
- Issue Sort Value:
- 2014-0016-0004-0000
- Page Start:
- 327
- Page End:
- 335
- Publication Date:
- 2013-08-26
- Subjects:
- Liver -- Diseases -- Periodicals
Biliary tract -- Diseases -- Periodicals
Pancreas -- Diseases -- Periodicals
616.362005 - Journal URLs:
- https://www.journals.elsevier.com/hpb/ ↗
http://www.hpbonline.org/current ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1477-2574 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/hpb.12149 ↗
- Languages:
- English
- ISSNs:
- 1365-182X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4335.262340
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 3828.xml